DrugRepV_0282 | Diclofenac | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Influenza virus | A/New Jersey/15/2007 | | Relative fluorescent unit | Decrease (50 %) | Approved | 26833677 |
DrugRepV_0283 | Diclofenac | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Influenza virus | A/Netherlands/026/2008 | | Relative fluorescent unit | Decrease (50 %) | Approved | 26833677 |
DrugRepV_0284 | Diclofenac | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Influenza virus | A/Netherlands /049/2008 | | Relative fluorescent unit | Decrease (50 %) | Approved | 26833677 |
DrugRepV_0285 | Diclofenac | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Influenza virus | A/Brisbane /56/2007 | | Relative fluorescent unit | Decrease (50 %) | Approved | 26833677 |
DrugRepV_1396 | Diclofenac Sodium salt | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (45.66 %) | Approved | 27476412 |
DrugRepV_2167 | Diclofenac Diethylamine | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Osteoarthritis and rheumatoid arthritis | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (40.6760631 %) | Approved | 27742486 |
DrugRepV_2170 | Diclofenac Potassium | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | No significant decrease (38.1915639 %) | Approved | 27742486 |
DrugRepV_2762 | Diclofenac | Dermatologicals; Musculo-Skeletal System and Sensory Organ | Fever and pain | Chikungunya virus | vAc-CHIKV 26S-Rhir-E | NA | Fusion index-Fluorescent Intensities | Increase (-4.1617635 %) | Approved | 27742486 |